OROS methylphenidate
OROS methylphenidate is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
2
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
0
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Quetiapine and Concerta in the Treatment for ADHD and Aggressive Behavior.
OROS Methylphenidate (Concerta) in the Treatment of Adult ADHD
The Impact of Osmotic Release Oral Delivery System Methylphenidate (OROS MPH) Upon Family of Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Proton Magnetic Spectroscopy in Children and Adolescents With ADHD Before and After Treatment With OROS Methylphenidate
Basic and Clinical Research on Attention Deficit Hyperactivity Disorder (ADHD)
Clinical Trials (5)
Quetiapine and Concerta in the Treatment for ADHD and Aggressive Behavior.
OROS Methylphenidate (Concerta) in the Treatment of Adult ADHD
The Impact of Osmotic Release Oral Delivery System Methylphenidate (OROS MPH) Upon Family of Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Proton Magnetic Spectroscopy in Children and Adolescents With ADHD Before and After Treatment With OROS Methylphenidate
Basic and Clinical Research on Attention Deficit Hyperactivity Disorder (ADHD)
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5